Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody
- PMID: 25288569
- DOI: 10.4049/jimmunol.1401467
Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody
Abstract
Heterozygous gain-of-function (GOF) mutations of STAT1 are responsible for chronic mucocutaneous candidiasis disease (CMCD), one of the primary immunodeficiency diseases characterized by susceptibility to mucocutaneous Candida infection. To date, 30 aa changes have been reported: 21 in the coiled-coil domain and 9 in the DNA-binding domain. In this study, we report two novel STAT1 GOF mutations of p.K278E in coiled-coil domain and p.G384D in DNA-binding domain in Japanese CMCD patients. Ectopic expression of these STAT1 mutants in HeLa cells was associated with increased phosphorylation of the mutant and the endogenous wild-type STAT1 due to impaired dephosphorylation, indicating heterodimers of the wild-type and mutant STAT1 cause impaired dephosphorylation, as did homodimers of the mutants. Because IL-17A production was not significantly reduced at least in one of the patients following PMA plus ionomycin stimulation, we further studied Th17-associated cytokines IL-17A, IL-17F, and IL-22 in response to more physiologically relevant stimulations. IL-17A and IL-22 production from PBMCs and CD4(+) cells was significantly reduced in four patients with STAT1 GOF mutations, including the previously reported R274Q in response to anti-CD3 plus anti-CD28 Abs or Candida stimulations. In contrast, IL-17F production was comparable to healthy controls in response to anti-CD3 plus anti-CD28 Abs stimulation. These results indicate impaired production of IL-17A and IL-22 rather than IL-17F was associated with the development of CMCD in these patients. Additionally, only the anti-IL-17F autoantibody was detected in sera from 11 of 17 patients with STAT1 GOF mutations, which may be useful as a marker for this disease.
Copyright © 2014 by The American Association of Immunologists, Inc.
Similar articles
-
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011 Aug 1;208(8):1635-48. doi: 10.1084/jem.20110958. Epub 2011 Jul 4. J Exp Med. 2011. PMID: 21727188 Free PMC article.
-
A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.Mol Immunol. 2015 Dec;68(2 Pt C):597-605. doi: 10.1016/j.molimm.2015.09.014. Mol Immunol. 2015. PMID: 26514428
-
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.J Med Genet. 2013 Sep;50(9):567-78. doi: 10.1136/jmedgenet-2013-101570. Epub 2013 May 24. J Med Genet. 2013. PMID: 23709754 Free PMC article.
-
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.Curr Opin Pediatr. 2013 Dec;25(6):715-21. doi: 10.1097/MOP.0000000000000028. Curr Opin Pediatr. 2013. PMID: 24240291 Review.
-
Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.Pediatr Allergy Immunol. 2021 Nov;32(8):1804-1812. doi: 10.1111/pai.13603. Epub 2021 Aug 9. Pediatr Allergy Immunol. 2021. PMID: 34289170 Review.
Cited by
-
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis.J Exp Med. 2015 May 4;212(5):619-31. doi: 10.1084/jem.20141065. Epub 2015 Apr 27. J Exp Med. 2015. PMID: 25918342 Free PMC article.
-
Gut microbiota from patients with arteriosclerotic CSVD induces higher IL-17A production in neutrophils via activating RORγt.Sci Adv. 2021 Jan 22;7(4):eabe4827. doi: 10.1126/sciadv.abe4827. Print 2021 Jan. Sci Adv. 2021. PMID: 33523954 Free PMC article.
-
STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses.NPJ Genom Med. 2021 May 14;6(1):34. doi: 10.1038/s41525-021-00196-7. NPJ Genom Med. 2021. PMID: 33990617 Free PMC article.
-
Fungal immunology in clinical practice: Magical realism or practical reality?Med Mycol. 2019 Jun 1;57(Supplement_3):S294-S306. doi: 10.1093/mmy/myy165. Med Mycol. 2019. PMID: 31292656 Free PMC article.
-
Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.Clin Exp Immunol. 2016 May;184(2):216-27. doi: 10.1111/cei.12746. Epub 2016 Feb 9. Clin Exp Immunol. 2016. PMID: 26621323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous